Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
PUT
3M
MMM
$92.3B
| $216M | 0.1% |
1,467,731
+326,986
| +29% | +$48.8M |
|
152
PUT
AutoZone
AZO
$48.3B
| $212M | 0.1% |
276,100
+135,400
| +96% | +$105M |
|
153
PUT
Humana
HUM
$45.5B
| $212M | 0.1% |
1,197,500
-320,500
| -21% | -$55.6M |
|
154
CALL
Mastercard
MA
$509B
| $211M | 0.1% |
2,075,100
-168,800
| -8% | -$16.2M |
|
155
CALL
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$268M
| $210M | 0.1% |
50
+39
| +355% | +$240M |
|
156
Netflix
NFLX
$331B
| $209M | 0.1% |
+21,215,080
| New | +$203M |
|
157
PUT
Walmart Inc
WMT
$825B
| $209M | 0.1% |
8,673,900
+104,700
| +1% | +$2.54M |
|
158
PUT
Intuitive Surgical
ISRG
$134B
| $207M | 0.1% |
2,567,700
+48,600
| +2% | +$3.72M |
|
159
PUT
State Street Utilities Select Sector SPDR ETF
XLU
$22.2B
| $206M | 0.1% |
8,403,400
+4,249,600
| +102% | +$108M |
|
|
CELG
160
PUT
DELISTED
Celgene Corp
CELG
| $203M | 0.1% |
1,939,200
+15,600
| +0.8% | +$1.69M |
|
161
CALL
AbbVie
ABBV
$468B
| $200M | 0.1% |
3,167,200
-320,100
| -9% | -$20.7M |
|
162
PUT
Coca-Cola
KO
$392B
| $199M | 0.1% |
4,696,300
+532,700
| +13% | +$23.3M |
|
|
LNKD
163
CALL
DELISTED
LinkedIn Corporation
LNKD
| $199M | 0.1% |
1,039,600
-326,400
| -24% | -$62.6M |
|
|
YHOO
164
CALL
DELISTED
Yahoo Inc
YHOO
| $198M | 0.1% |
4,598,800
-394,500
| -8% | -$16.2M |
|
165
PUT
Intel
INTC
$476B
| $197M | 0.09% |
5,208,100
+140,100
| +3% | +$4.96M |
|
166
CALL
Marathon Petroleum
MPC
$101B
| $196M | 0.09% |
4,834,400
-439,900
| -8% | -$17.8M |
|
167
PUT
Bausch Health
BHC
$2.41B
| $195M | 0.09% |
7,924,600
+671,600
| +9% | +$17.4M |
|
168
iShares Silver Trust
SLV
$33.8B
| $194M | 0.09% |
10,682,245
+7,668,343
| +254% | +$143M |
|
169
CALL
Eli Lilly
LLY
$1.12T
| $193M | 0.09% |
2,407,100
+292,200
| +14% | +$23.4M |
|
170
PUT
Qualcomm
QCOM
$169B
| $192M | 0.09% |
2,799,300
+18,000
| +0.6% | +$1.09M |
|
171
PUT
Amgen
AMGN
$238B
| $191M | 0.09% |
1,145,900
+111,800
| +11% | +$18.9M |
|
172
CALL
NVIDIA
NVDA
$5.2T
| $190M | 0.09% |
110,864,000
+7,192,000
| +7% | +$10.6M |
|
173
PUT
Wynn Resorts
WYNN
$10.3B
| $190M | 0.09% |
1,948,500
+341,400
| +21% | +$33.3M |
|
174
PUT
General Motors
GM
$77.2B
| $189M | 0.09% |
5,951,800
+211,600
| +4% | +$6.61M |
|
175
CALL
McDonald's
MCD
$192B
| $188M | 0.09% |
1,633,700
-570,800
| -26% | -$67.6M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.